Roivant Sciences Ltd. (NASDAQ:ROIV) appears in 431 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 77,981,253 | 12,201,789 | 18.55% | $2,160,080,715.00 |
| Morgan Stanley | 31 Mar, 2026 | 51,828,325 | -6,531,228 | -11.19% | $1,435,644,662.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 44,254,260 | 3,083,785 | 7.49% | $1,225,842,982.00 |
| QVT Financial LP | 31 Mar, 2026 | 25,161,237 | -1,225,784 | -4.65% | $696,966,265.00 |
| UBS Group AG | 31 Mar, 2026 | 22,619,472 | 4,228,680 | 22.99% | $626,559,375.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 20,680,572 | 20,680,572 | 0.00% | $572,851,844.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 19,838,698 | 19,838,698 | 0.00% | $549,531,935.00 |
| State Street Corp | 31 Mar, 2026 | 16,186,613 | -1,174,852 | -6.77% | $448,369,180.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 12,794,097 | 2,116,203 | 19.82% | $354,396,487.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 11,111,591 | -10,853,725 | -49.41% | $307,791,071.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 10,182,477 | 2,028,931 | 24.88% | $282,113,040.00 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 31 Mar, 2026 | 9,675,000 | 9,638,000 | 26,048.65% | $267,997,500.00 |
| Two Seas Capital LP | 31 Mar, 2026 | 9,328,291 | -463,600 | -4.73% | $258,393,661.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 8,285,461 | 300,000 | 3.76% | $229,507,270.00 |
| Patient Square Capital LP | 31 Mar, 2026 | 8,166,047 | 0 | 0.00% | $226,199,502.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 7,475,866 | -1,771,602 | -19.16% | $207,004,200.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 7,076,488 | 139,376 | 2.01% | $196,018,718.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 6,992,136 | 6,992,136 | 0.00% | $193,683.00 |
| Darwin Global Management, Ltd. | 31 Mar, 2026 | 6,797,300 | 6,797,300 | 0.00% | $179,516,693.00 |
| VIKING GLOBAL INVESTORS LP | 31 Mar, 2026 | 6,652,448 | 209,257 | 3.25% | $184,272,810.00 |